Trojer Patrick 4

4 · CONSTELLATION PHARMACEUTICALS INC · Filed May 7, 2020

Form 4

Period: 2020-05-06

Chief Scientific Officer

Transactions

Exercise/Conversion
Common Stock
2020-05-06$7.60/sh+7,164$54,446→ 7,164 total
Exercise/Conversion
Common Stock
2020-05-06$5.62/sh+2,836$15,938→ 10,000 total
Sale
Common Stock
2020-05-06$45.16/sh−10,000$451,553→ 0 total
Exercise/Conversion
Stock Option (Right to Buy)
2020-05-06−2,836→ 0 total
Exercise: $5.62Exp: 2025-11-08→ Common Stock (2,836 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2020-05-06−7,164→ 33,330 total
Exercise: $7.60Exp: 2028-03-05→ Common Stock (7,164 underlying)

Footnotes (4)

[F1]These trades were made pursuant to a Rule 10b5-1 trading plan.
[F2]This transaction was executed in multiple trades at prices ranging from $45.00 to $45.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F3]This option was granted on March 6, 2018, and the shares underlying the options vest in equal quarterly installments through March 6, 2022.
[F4]This option was granted on November 9, 2015, and is fully vested.

Documents

1 file